We are pleased to announce the fourth online seminar in the GENEGUT Seminar Series, featuring Dr. Matthew O’Connor, CEO of Scientific Affairs and Director at Cyclarity Therapeutics. The seminar, titled “Engineering and producing cyclodextrins for medical applications”, will take place on 2 July 2026 from 17:00–18:00 CET.
Register here to attend:
This seminar is organised by GENEGUT together with Future Medicines and the School of Pharmacy, University College Cork, bringing together expertise from academia and industry to explore emerging solutions in drug delivery and therapeutic innovation.
About Dr. Matthew “Oki” O’Connor
Dr. O’Connor earned his master’s degree in neuroscience from Northwestern Medical School in 1999 and his Ph.D. in Biochemistry from Baylor College of Medicine in 2005. His postdoctoral research at UC Berkeley focused on muscle stem cells and aging. Prior to joining Cyclarity Therapeutics, he served as Vice President of Research at the SENS Research Foundation, where he oversaw a broad portfolio of rejuvenation biotechnology programs spanning multiple therapeutic areas. He has authored numerous scientific publications and patents related to aging and age-related disease research.